S2 Episode 1: Psoriasis Advocacy: A Model for Every Chronic Disease? S2 Episode 1: Psoriasis Advocacy: A Model for Every Chronic Disease?
Dr Steven Feldman and Leah Howard, National Psoriasis Foundation president and CEO, discuss how an unseen and unheard patient population has begun to step out and speak up — at the US Capitol and beyond.Medscape (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - April 25, 2023 Category: Orthopaedics Tags: Dermatology InDiscussion Source Type: news
NPF Provides Guidance for Virtual Psoriasis Visits NPF Provides Guidance for Virtual Psoriasis Visits
In some cases, telemedicine may allow dermatologists specializing in psoriasis care to extend their reach in comanaging patients with primary care physicians and community dermatologists.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - April 24, 2023 Category: Dermatology Tags: Dermatology News Source Type: news
Amgen Wins Appeal in US Patent Case Over Generic Psoriasis Drugs Amgen Wins Appeal in US Patent Case Over Generic Psoriasis Drugs
Amgen convinced a US appeals court on Wednesday to uphold patents that barred generic versions of its blockbuster psoriasis drug Otezla proposed by Zydus Pharmaceuticals and Novartis ' Sandoz.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 20, 2023 Category: Consumer Health News Tags: Dermatology News Source Type: news
Good Agreement for Clinical, Photograph Assessment of Psoriasis
THURSDAY, April 20, 2023 -- There is good agreement between psoriasis severity assessed clinically and by photographs, according to a study recently published in JAAD International.
Zarqa Ali, M.D., Ph.D., from Copenhagen University Hospital... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 20, 2023 Category: Pharmaceuticals Source Type: news
Child With Psoriasis Negatively Impacts Mom's Quality of Life
WEDNESDAY, April 19, 2023 -- A child with psoriasis can have a negative effect on the mother ' s quality of life, according to a study published online March 31 in the Journal of Cosmetic Dermatology.
EmadEldin Abd Elmoneim Elgamal, M.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 19, 2023 Category: Pharmaceuticals Source Type: news
COVID-19 and Psoriasis: Is There a Link? COVID-19 and Psoriasis: Is There a Link?
"Psoriasis flares have long been associated with bacterial and viral infections, particularly a form of psoriasis called guttate."WebMD Health News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - April 19, 2023 Category: Dermatology Tags: Dermatology News Source Type: news
COVID-19 and Psoriasis: Is There a Link?
New research is shedding light on how an infection with COVID-19 may reactivate, or even cause, psoriasis. (Source: WebMD Health)
Source: WebMD Health - April 19, 2023 Category: Consumer Health News Source Type: news
Four in 10 Psoriasis Patients Report High Shared Decision-Making
WEDNESDAY, April 12, 2023 -- Less than half of psoriasis patients report high levels of shared decision-making, according to a study published online April 1 in the Journal of the American Academy of Dermatology.
Danielle Yee, M.D., from the Keck... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 12, 2023 Category: Pharmaceuticals Source Type: news
Psoriasis Highlights From AAD 2023 Psoriasis Highlights From AAD 2023
Highlights in psoriasis and related disorders from AAD 2023 include data on secukinumab, adalimumab, and deucravacitinib, as reported by Dr Joel Gelfand.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 10, 2023 Category: Consumer Health News Tags: None ReCAP Source Type: news
Study Finds Gaps in CV Risk Screening of Patients With Psoriasis Study Finds Gaps in CV Risk Screening of Patients With Psoriasis
"Continued efforts to develop effective interventions to improve CV screening and care for people with psoriasis in all regions of the U.S. are needed," according to the authors.MDedge News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 3, 2023 Category: Cardiology Tags: Dermatology News Source Type: news
FDA Approves New Formulation of Hyrimoz Adalimumab Biosimilar FDA Approves New Formulation of Hyrimoz Adalimumab Biosimilar
The agency approved a higher concentration formulation of Hyrimoz for its previous indications, including rheumatoid arthritis and psoriasis.Medscape Medical News (Source: Medscape Pediatrics Headlines)
Source: Medscape Pediatrics Headlines - March 27, 2023 Category: Pediatrics Tags: Rheumatology News Alert Source Type: news
New Data Forecast More Oral PDE4 Inhibitors for Psoriasis New Data Forecast More Oral PDE4 Inhibitors for Psoriasis
A new oral phosphodiesterase-4 (PDE4) inhibitor achieved impressive rates of complete or near-complete skin clearance in a phase 2 study that also found the drug was well tolerated.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 25, 2023 Category: Allergy & Immunology Tags: Dermatology News Source Type: news
The Petri Dish: Takeda scores win from Nimbus licensing deal; Biogen exits partnership
Takeda paid Nimbus Therapeutics $4 billion for a psoriasis drug in December. It just met its primary goal in a midstage trial. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - March 23, 2023 Category: Health Management Authors: Rowan Walrath Source Type: news
Smoking Independently Tied to Higher Risk for Psoriasis
TUESDAY, March 21, 2023 -- Smoking is tied to an increased risk for psoriasis, but may not be a cause of psoriasis, according to a study published online Feb. 22 in Frontiers in Immunology.
Charlotte Näslund-Koch, from Copenhagen University... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 21, 2023 Category: Pharmaceuticals Source Type: news
